Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis is a research paper published in Advanced Healthcare Materials (2020). On theSindex it has a DataRank of 0.468. It has been cited 10 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.108
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
American Heart Association
Grant: 18POST33990231
National Institutes of Health
Grant: R01HL128847
National Institutes of Health
Grant: R01HL098228
National Institutes of Health
Grant: T32AI106704
National Institutes of Health
Grant: F32HL144120
National Institutes of Health
Grant: F31HL145962
National Institutes of Health
Grant: 7R01HL098228-04
Mechanisms of Vascular Neotissue Formation In Tissue Engineered Vascular Grafts
National Institutes of Health
Grant: 1F32HL144120-01A1
Modulating the Host Response to Tissue Engineered Vascular Grafts
National Institutes of Health
Grant: 1F31HL145962-01
Targeting LYST-Mediated Tissue-Engineered Vascular Graft Stenosis
National Institutes of Health
Grant: 5T32AI106704-09
Advanced Research Training in Immunology for Surgery Trainees (ARTIST)
National Institutes of Health
Grant: 5R01HL128847-04
Development of an Improved Vascular Graft for Use in Congenital Heart Surgery
FWCI
0.58
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords